Cross-docking and molecular dynamic studies to achieve the potent antiviral HIV-1 nonnucleoside reverse transcriptase inhibitors. Sci. Ess. J [Internet]. 2023 Nov. 17 [cited 2026 Oct. 23];39(2):23-37. Available from: https://ejournals.swu.ac.th/sej/article/view/15577